Basic Information
| LncRNA/CircRNA Name | CARLo-5 |
| Synonyms | CCAT1, CARLo-5, onco-lncRNA-40 |
| Region | GRCh38_8:127207382-127219268 |
| Ensemble | ENSG00000247844 |
| Refseq | NR_108049 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 |
| Methods | qPCR, Western blot, RIP, ChIP etc. |
| Sample | HCC tissues, cells lines (MHCC-97H, SMCC-7721 MHCC97L, L02) |
| Expression Pattern | up-regulated |
| Function Description | CARLo-5 expression was significantly higher in HCC tissues and upregulated CARLo-5 expression was closely correlated with tumor size and advanced tumor stage. higher CARLo-5 expression predicted a poor prognosis for HCC patients and was an independent risk factor for OS in HCC patients. CARLo-5 inhibited the miR-200b expression via EZH2. CARLo-5 represented a novel tumor biomarker and therapeutic target for HCC. |
| Pubmed ID | 29050269 |
| Year | 2017 |
| Title | Long non-coding RNA CARLo-5 promotes tumor progression in hepatocellular carcinoma via suppressing miR-200b expression. |
External Links
| Links for CARLo-5 | GenBank HGNC NONCODE |
| Links for hepatocellular carcinoma | OMIM COSMIC |